Debating the Future of Pharmaceutical Advertising in the U.S.

This chapter explores the potential effects of a Senate bill that seeks to eliminate direct-to-consumer pharmaceutical advertising. It delves into the arguments surrounding the bill, presenting statistics on medication usage and discussing the historical context of pharmaceutical marketing's impact on healthcare challenges.